Yeye Hu , Ziliang He , Weijie Dai , Xuejunlan Hu , Haiyue Hu , Yuhao Wang , Lei Huang , Canglang Mou , Jinghan Su , Weizhaole Wei , Haifeng Wu , Long You , Honggang Wang , Jae Youl Cho , Weicheng Hu
{"title":"Protopanaxatriol enhances mucin expression in intestinal epithelial cells and mice","authors":"Yeye Hu , Ziliang He , Weijie Dai , Xuejunlan Hu , Haiyue Hu , Yuhao Wang , Lei Huang , Canglang Mou , Jinghan Su , Weizhaole Wei , Haifeng Wu , Long You , Honggang Wang , Jae Youl Cho , Weicheng Hu","doi":"10.1016/j.jgr.2026.100992","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Mucins are critical components of the intestinal mucus layer that protects the gut epithelium and maintains microbiota balance. Protopanaxatriol (PPT), an active metabolite derived from protopanaxatriol-type saponins, has shown promise in modulating gut health, but its effects on mucin expression remain poorly understood.</div></div><div><h3>Objective</h3><div>This study aimed to investigate the effects of PPT on mucin expression in human intestinal epithelial Caco-2 cells and in a mouse model.</div></div><div><h3>Methods</h3><div>Caco-2 cells were treated with different concentrations of PPT, and the expression of mucins was assessed via qRT-PCR and Western blot analysis. In parallel, mice were administered PPT orally, and tissues were collected for mucin quantification.</div></div><div><h3>Results</h3><div>PPT treatment significantly upregulated mucin expression at both the mRNA and protein levels in Caco-2 cells. <em>In vivo</em>, mice administered with PPT exhibited significantly elevated mucin expression in the colon. In addition, PPT administration also induced mucin expression in both lung and stomach tissues.</div></div><div><h3>Conclusion</h3><div>PPT promoted mucin expression in human intestinal epithelial cells and in the gut of mice, suggesting their potential as natural agents for maintaining gut health and preventing intestinal disorders.</div></div>","PeriodicalId":16035,"journal":{"name":"Journal of Ginseng Research","volume":"50 3","pages":"Article 100992"},"PeriodicalIF":5.6000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ginseng Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1226845326000187","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/10 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Mucins are critical components of the intestinal mucus layer that protects the gut epithelium and maintains microbiota balance. Protopanaxatriol (PPT), an active metabolite derived from protopanaxatriol-type saponins, has shown promise in modulating gut health, but its effects on mucin expression remain poorly understood.
Objective
This study aimed to investigate the effects of PPT on mucin expression in human intestinal epithelial Caco-2 cells and in a mouse model.
Methods
Caco-2 cells were treated with different concentrations of PPT, and the expression of mucins was assessed via qRT-PCR and Western blot analysis. In parallel, mice were administered PPT orally, and tissues were collected for mucin quantification.
Results
PPT treatment significantly upregulated mucin expression at both the mRNA and protein levels in Caco-2 cells. In vivo, mice administered with PPT exhibited significantly elevated mucin expression in the colon. In addition, PPT administration also induced mucin expression in both lung and stomach tissues.
Conclusion
PPT promoted mucin expression in human intestinal epithelial cells and in the gut of mice, suggesting their potential as natural agents for maintaining gut health and preventing intestinal disorders.
期刊介绍:
Journal of Ginseng Research (JGR) is an official, open access journal of the Korean Society of Ginseng and is the only international journal publishing scholarly reports on ginseng research in the world. The journal is a bimonthly peer-reviewed publication featuring high-quality studies related to basic, pre-clinical, and clinical researches on ginseng to reflect recent progresses in ginseng research.
JGR publishes papers, either experimental or theoretical, that advance our understanding of ginseng science, including plant sciences, biology, chemistry, pharmacology, toxicology, pharmacokinetics, veterinary medicine, biochemistry, manufacture, and clinical study of ginseng since 1976. It also includes the new paradigm of integrative research, covering alternative medicinal approaches. Article types considered for publication include review articles, original research articles, and brief reports.
JGR helps researchers to understand mechanisms for traditional efficacy of ginseng and to put their clinical evidence together. It provides balanced information on basic science and clinical applications to researchers, manufacturers, practitioners, teachers, scholars, and medical doctors.